Accordingly, concomitant expression of NFATc1 and EZH2 was also detected in invasive pancreatic tumors of the fast-progressing KPC model [20] (Figure 1B) and in a PDAC Patient-Derived Xenograft (PDX) model (Figure 1C). Here, NFATC1 is linked to pancreatic neoplasm.